Universitatsklinikum des Saarlandes

• 2026 Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format